1. Home
  2. AVTX vs YGMZ Comparison

AVTX vs YGMZ Comparison

Compare AVTX & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • YGMZ
  • Stock Information
  • Founded
  • AVTX 2011
  • YGMZ 2002
  • Country
  • AVTX United States
  • YGMZ China
  • Employees
  • AVTX N/A
  • YGMZ N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • YGMZ Transportation Services
  • Sector
  • AVTX Health Care
  • YGMZ Consumer Discretionary
  • Exchange
  • AVTX Nasdaq
  • YGMZ Nasdaq
  • Market Cap
  • AVTX 88.4M
  • YGMZ 73.6M
  • IPO Year
  • AVTX 2015
  • YGMZ 2020
  • Fundamental
  • Price
  • AVTX $8.46
  • YGMZ $0.76
  • Analyst Decision
  • AVTX Strong Buy
  • YGMZ
  • Analyst Count
  • AVTX 7
  • YGMZ 0
  • Target Price
  • AVTX $34.33
  • YGMZ N/A
  • AVG Volume (30 Days)
  • AVTX 109.6K
  • YGMZ 41.0K
  • Earning Date
  • AVTX 05-12-2025
  • YGMZ 01-01-0001
  • Dividend Yield
  • AVTX N/A
  • YGMZ N/A
  • EPS Growth
  • AVTX N/A
  • YGMZ N/A
  • EPS
  • AVTX N/A
  • YGMZ N/A
  • Revenue
  • AVTX $441,000.00
  • YGMZ $55,805,416.00
  • Revenue This Year
  • AVTX N/A
  • YGMZ N/A
  • Revenue Next Year
  • AVTX N/A
  • YGMZ N/A
  • P/E Ratio
  • AVTX N/A
  • YGMZ N/A
  • Revenue Growth
  • AVTX N/A
  • YGMZ N/A
  • 52 Week Low
  • AVTX $5.99
  • YGMZ $0.64
  • 52 Week High
  • AVTX $22.47
  • YGMZ $4.35
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 56.89
  • YGMZ 40.30
  • Support Level
  • AVTX $7.88
  • YGMZ $0.80
  • Resistance Level
  • AVTX $9.00
  • YGMZ $0.99
  • Average True Range (ATR)
  • AVTX 0.81
  • YGMZ 0.11
  • MACD
  • AVTX 0.12
  • YGMZ -0.02
  • Stochastic Oscillator
  • AVTX 54.41
  • YGMZ 1.90

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About YGMZ MingZhu Logistics Holdings Limited

MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.

Share on Social Networks: